This could help the issue being PET scan not standard of care in Australia or US. The more likely scenario playing out is Cardio Protect gets breakthrough designation and is 1st pathway to approval. Then EMD AML to follow. They haven't kicked off EUR and 10 sites for a reason and i'm not convinced its all to do with EMA approval?
RAC Price at posting:
$1.48 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)